Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Phase 2b    crawled date : 2021 - 08 - 05    save search

Exicure Provides Interim Results from Ongoing Phase 1b/2 Clinical Trial of Cavrotolimod (AST-008)
Published: 2021-08-05 (Crawled : 12:15) - biospace.com/
XCUR 4 | $0.515 19K twitter stocktwits trandingview |
Commercial Services
| | O: -1.42% H: 1.44% C: -5.04%

ongoing phase 1 results trial phase 1b phase 2b
Monopar Reaches Target Number of Clinical Sites in Phase 2b Portion of 2b/3 Validive® VOICE Trial
Published: 2021-08-05 (Crawled : 12:15) - globenewswire.com
MNPR | $0.657 1.08% -3.17% 31 twitter stocktwits trandingview |
Health Technology
| | O: 3.92% H: 0.38% C: -1.7%

phase 2 phase 2b trial
Data from Medivir's MIV-818 phase 1b study to be presented at the ESMO Congress
Published: 2021-08-05 (Crawled : 08:00) - prnewswire.com
IGMS | $7.96 3.38% 3.14% 27 twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 15.53% C: 14.73%

phase 1 phase 1b phase 2b
Gainers vs Losers
50% 50%

Top 10 Gainers
CSSE 4 | $0.299 96.32% 7M twitter stocktwits trandingview |
Consumer Services

BRFH 4 | $1.99 80.91% 13M twitter stocktwits trandingview |
Manufacturing

BOF | $1.915 63.68% 620K twitter stocktwits trandingview |

AMST | $3.13 56.5% 500K twitter stocktwits trandingview |
Technology Services

ACON | $0.3595 24.83% 3.5M twitter stocktwits trandingview |
n/a

CDTX | News | $14.57 18.55% 330K twitter stocktwits trandingview |
Health Technology

ULBI M | $10.12 15.92% 120K twitter stocktwits trandingview |
Producer Manufacturing

LRHC | $1.79 11.88% 3K twitter stocktwits trandingview |
n/a

AIXI | $1.34 8.94% 42K twitter stocktwits trandingview |
n/a

TRU | $74.475 8.44% 100K twitter stocktwits trandingview |
Technology Services


Your saved searches
Save your searches and get alerts when important news are released.